These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Not reported 2004-000415-26 A DOUBLE-BLIND, DOSE-RANGE, PLACEBO CONTROLLED STUDY OF THE EFFECTS OF PST2238 VS. PLACEBO IN PATIENTS WITH STABLE, UNCOMPLICATED, ESSENTIAL HYPERTENSION. 2007-12-31 due-trials
Completed, but no date Terminated 2004-001043-30 A non-comparative, randomized phase II study of two different oral schedules of gimatecan (ST1481) as second line therapy for patients with advanced Non Small Cell Lung Cancer (NSCLC) bad-data
Exempt, with results 2004-001114-14 BIOAVAILABILITY AND BIOEQUIVALENCE OF TWO ORAL FORMULATION OF L-PROPIONYLCARNITINE TABLET VS SACHET IN HEALTHY VOLUNTEERS AT THE DOSE OF 2 G OPEN, RANDOMISED, TWO-WAYS CROSS-OVER, SINGLE DOSE STUDY not-yet-due
Ongoing 2004-001277-25 A Phase III, Multicentre, Double Blinded Study In Patients With Chronic Hepatitis C Who Are Non-Responders To Prior Peginterferon Alpha + Ribavirin Therapy Comparing Treatment With Thymosin Alpha 1 + ... not-yet-due
Ongoing 2004-001927-39 A PHASE II, MULTICENTER, UNCONTROLLED, OPEN STUDY IN PATIENTS WITH CHRONIC HEPATITIS C WHO ARE INTOLERANT TO INTERFERONS THERAPY TO EVALUATE THE SAFETY AND EFFICACY OF A TREATMENT WITH THYMOSIN ALPHA ... not-yet-due
Ongoing 2004-005106-79 Phase II study of gimatecan (ST 1481) as salvage treatment in patients with advanced breast cancer after anthracycline /taxanes-based chemotherapy regimen not-yet-due
Reported results 2005-000004-13 EVALUATION OF ACETYL -L-CARNITINE ST 200 TO REDUCE INTENSITY OF TAXANES- OR PLATINUM-INDUCED SENSORY NEUROPATHY 2008-09-02 due-trials
Listed as ongoing, but also has a completion date 2005-000595-40 A Phase II study of oral gimatecan ST 1481 in progressing or recurring patients with advanced epithelial ovarian, fallopian or peritoneal cancer, previously treated with platinum and taxanes 2006-12-15 bad-data
Completed, but no date Terminated 2005-001508-38 Phase II Explorative Study of Acetyl-L-Carnitine (ST 200) for Vincristine-Induced Neurotoxicity in Patients With Acute Lymphoblastic Leukemia (ALL). bad-data
Listed as ongoing, but also has a completion date 2005-001951-39 "Estudio fase II de Gimatecan (ST1481) como tratamiento de rescate en pacientes con sarcoma de partes blandas avanzado o metastático y recidivados después de un régimen de quimioterapia basado en antr... 2007-10-04 bad-data
Reported results 2005-003471-20 Phase II, Parallel-group, Placebo Controlled, Double-blind, Randomized, Multicenter Study to investigate the efficacy of Two Dosages of Propionyl-L-carnitine ST 261 Colon Release Tablets in Patients... 2009-06-18 due-trials
Not reported 2005-004500-37 A Randomized, Double-Blind, Placebo-Controlled, Dose-Response Study of the Safety and Efficacy of Thymosin Beta 4 in the Treatment of Patients with Venous Stasis Ulcers 2009-03-12 due-trials
Completed, but no date, and reported results 2005-004664-23 The role of Acetyl-L-Carnitine in Reflex Sympathetic Dystrophy RDS and in Complex Regional Pain Syndrome CRPS .Pilot clinical trial. bad-data
Completed, but no date, and reported results 2005-004665-42 Evaluation of the efficacy and tollerability of long-term somministration of Acetyl-l-carnitine in the treatment of HIV related lipodystrophy.Parallel group, randomized, double blind, controlled versu... bad-data
Not reported 2005-004972-20 A Phase II Study to assess the hemodynamic effects of ISTAROXIME, a novel lusinotropic agent, in patients hospitalized with worsening heart failure and a reduced left ventricular systolic function. 2007-07-05 due-trials
Not reported 2009-016362-85 A PILOT, RANDOMIZED, SINGLE SITE, 3 PARALLEL ARMS, OPEN-LABEL STUDY IN PATIENTS ON CHRONIC DIALYSIS WITH END STAGE RENAL DISEASE (ESRD) TO EVALUATE THE ENHANCING EFFECT OF TWO DOSES OF THYMOSIN ALPHA ... 2010-11-04 due-trials
Completed, but no date 2009-016982-26 Neuronal conduction along the visual patways after oral treatment with Acetyl-L-carnitine in patients with Leber’s Hereditary Optic Neuropathy bad-data
Reported results 2011-004765-32 Phase III, Parallel-group, Placebo Controlled, Double-blind, Randomized, Multicenter International Study to Investigate the Safety and Efficacy of Propionyl-L-Carnitine (ST261) Modified Release Tablet... 2013-08-13 due-trials
Reported results 2011-004770-28 Phase III, Parallel-group, Placebo Controlled, Double-blind, Randomized, Multicenter International Study to Investigate the Safety and Efficacy of Propionyl-L-Carnitine (ST261) Modified Release Tablet... 2013-08-13 due-trials
Trial is outside EEC, and reported results 2013-002255-15 A phase II, open-label, multicentre, pharmacokinetic, pharmacodynamics and safety study of a new paediatric eurartesim dispersible formulation and crushed film coated eurartesim tablet, in infant pati... bad-data
Reported results 2013-003763-56 Proof of Concept Study of Eurartesim® in Patients with Imported Uncomplicated Plasmodium Vivax Malaria 2016-12-31 due-trials
Completed, but no date 2014-002289-62 Electroneurographic and clinical evaluation in patients with mild / moderate Carpal Tunnel Syndrome , following conservative pharmacological treatment with Nicetile®. bad-data

Related organisations

Over time organisations can merge, or split.

We think SIGMA-TAU is now effectively part of Alfasigma.